BMS to Acquire Mirati Therapeutics in a $4.8 Billion Deal
Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into a definitive merger agreement with US-based oncology...
Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into a definitive merger agreement with US-based oncology...
Global pharmaceutical company Bristol-Myers Squibb (BMS; NYSE: BMY) has announced an expansion of its existing...
Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422), through its innovative drug development subsidiary Sichuan Kelun-Biotech...
Bristol-Myers Squibb (BMS; NYSE: BMY) has released the final results from a Phase II trial...
US pharmaceutical major Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into a licensing and cooperation...
Bristol-Myers Squibb (BMS; NYSE: BMY) has received an indication extension approval from the US Food...
The Department of Health and Human Services (HHS) in the US has released a list...
Pharmaceutical giant Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into an agreement with cell therapy...
Bristol-Myers Squibb (BMS, NYSE: BMY) has released new data from a Phase I/II trial featuring...
The GuangDong Pharmaceutical Association has released the 2023 version of its off-label drug list, marking...
BeiGene (NASDAQ: BGNE) has announced a settlement and termination agreement with US firm Bristol-Myers Squibb/Celgene...
US pharmaceutical company Bristol-Myers Squibb (BMS; NYSE: BMY) has released its financial report for the...
United States-based Johnson & Johnson (J&J, NYSE: JNJ) has filed a lawsuit this week, challenging...
China-based biopharmaceutical company Antengene Corp., Ltd (HKG: 6996) has announced the first patient dosing in...
Sino-US biotech firm LianBio (OTCMKTS: LIANY) has announced the signing of a clinical supply agreement...
The National Medical Products Administration (NMPA) website has indicated that Israel-based Teva Pharmaceutical Industries’ (NYSE:...
The Center for Drug Evaluation (CDE) has indicated on its website that China-based biotech firm...
Shanghai Henlius Biotech, Inc (HKG: 2696) has announced receiving clinical trial approval from the National...
Several multinational companies (MNCs) have released their Q1 2023 financials, showing a varied performance over...
Global pharmaceutical company Bristol-Myers Squibb (BMS, NYSE: BMY) has announced the market launch in China...